Poseida Therapeutics Inc. (PSTX): Price and Financial Metrics Recent IPO


Poseida Therapeutics Inc. (PSTX) Recent IPO

Today's Latest Price: $11.10 USD

0.12 (-1.07%)

Updated Nov 24 4:00pm

Add PSTX to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 240 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

PSTX Stock Price Chart Interactive Chart >

Price chart for PSTX

PSTX Price/Volume Stats

Current price $11.10 52-week high $17.62
Prev. close $11.22 52-week low $7.63
Day low $10.82 Volume 64,000
Day high $11.40 Avg. volume 330,202
50-day MA $10.28 Dividend yield N/A
200-day MA $0.00 Market Cap 686.20M

Poseida Therapeutics Inc. (PSTX) Company Bio


Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of non-viral gene engineering technologies for the treatment of hematological malignancies and solid tumors. Its products pipeline include autologous and allogeneic chimeric antigen receptor T cell, or CAR-T. The company was founded by Eric M. Ostertag in 2014 and is headquartered in San Diego, CA.


PSTX Latest News Stream


Event/Time News Detail
Loading, please wait...

PSTX Latest Social Stream


Loading social stream, please wait...

View Full PSTX Social Stream

Latest PSTX News From Around the Web

Below are the latest news stories about Poseida Therapeutics Inc that investors may wish to consider to help them evaluate PSTX as an investment opportunity.

Poseida Therapeutics' cancer drug trial halted after patient dies

Poseida Therapeutics (PSTX) -34.5% after-hours on disclosing that the Food and Drug Administration halted a safety trial of the company's P-PSMA-101 prostate cancer treatment because of the death of a patient enrolled in the study.The clinical investigator on the study says the death was "possibly" related to the treatment, with further...

Seeking Alpha | August 18, 2020

Poseida Therapeutics prices upsized IPO at $16

Poseida Therapeutics (PSTX) has priced its IPO of 14.0M (from 10M) common shares at $16 per share. Gross proceeds should be $224M.Underwriters' over-allotment is an additional 2.1M shares.Trading should commence today.Poseida Therapeutics on deck for $115M IPO...

Seeking Alpha | July 9, 2020

Read More 'PSTX' Stories Here

PSTX Price Returns

1-mo -3.48%
3-mo 28.92%
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7799 seconds.